Have a feature idea you'd love to see implemented?
Let us know!
OPRX OptimizeRx Corp
Price (delayed)
$4.49
Market cap
$82.71M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.34
Enterprise value
$102.3M
OptimizeRx is a digital health company that provides communications solutions for life science companies, physicians and patients. Connecting over half of healthcare providers in the U.S. and millions of patients
Highlights
The gross profit is up by 47% year-on-year and by 7% since the previous quarter
OPRX's revenue is up by 40% year-on-year and by 6% since the previous quarter
OptimizeRx's quick ratio has shrunk by 73% YoY but it has increased by 11% QoQ
The net income has dropped by 76% year-on-year and by 35% since the previous quarter
OptimizeRx's EPS has plunged by 68% YoY and by 33% from the previous quarter
Key stats
What are the main financial stats of OPRX
Market
Valuations
Earnings
Shares outstanding
18.42M
Market cap
$82.71M
Enterprise value
$102.3M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.72
Price to sales (P/S)
0.93
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.16
Revenue
$88.18M
EBIT
-$27.28M
EBITDA
-$23.04M
Free cash flow
-$1.11M
Per share
Balance sheet
Liquidity
EPS
-$1.34
Free cash flow per share
-$0.06
Book value per share
$6.25
Revenue per share
$4.81
TBVPS
$2.61
Total assets
$165.2M
Total liabilities
$50.73M
Debt
$35.72M
Equity
$114.47M
Working capital
$32.4M
Debt to equity
0.31
Current ratio
3.23
Quick ratio
2.93
Net debt/EBITDA
-0.85
Margins
Efficiency
Dividend
EBITDA margin
-26.1%
Gross margin
62.6%
Net margin
-27.4%
Operating margin
-32%
Return on assets
-13.9%
Return on equity
-20%
Return on invested capital
-49.4%
Return on capital employed
-18.1%
Return on sales
-30.9%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
OPRX stock price
How has the OptimizeRx stock price performed over time
Intraday
1.58%
1 week
10.59%
1 month
-26.03%
1 year
-53.81%
YTD
-68.62%
QTD
-41.84%
Financial performance
How have OptimizeRx's revenue and profit performed over time
Revenue
$88.18M
Gross profit
$55.2M
Operating income
-$28.24M
Net income
-$24.17M
Gross margin
62.6%
Net margin
-27.4%
The net income has dropped by 76% year-on-year and by 35% since the previous quarter
The operating income has plunged by 73% YoY and by 22% from the previous quarter
The gross profit is up by 47% year-on-year and by 7% since the previous quarter
OPRX's revenue is up by 40% year-on-year and by 6% since the previous quarter
Growth
What is OptimizeRx's growth rate over time
Valuation
What is OptimizeRx stock price valuation
P/E
N/A
P/B
0.72
P/S
0.93
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.16
OptimizeRx's EPS has plunged by 68% YoY and by 33% from the previous quarter
The price to book (P/B) is 84% less than the 5-year quarterly average of 4.4 and 58% less than the last 4 quarters average of 1.7
OPRX's equity is down by 5% since the previous quarter
The stock's P/S is 89% below its 5-year quarterly average of 8.3 and 63% below its last 4 quarters average of 2.5
OPRX's revenue is up by 40% year-on-year and by 6% since the previous quarter
Efficiency
How efficient is OptimizeRx business performance
The ROIC has dropped by 157% year-on-year and by 36% since the previous quarter
The return on equity has dropped by 75% year-on-year and by 36% since the previous quarter
OptimizeRx's ROS has decreased by 42% YoY and by 18% from the previous quarter
The return on assets has declined by 29% year-on-year and by 28% since the previous quarter
Dividends
What is OPRX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for OPRX.
Financial health
How did OptimizeRx financials performed over time
OptimizeRx's quick ratio has shrunk by 73% YoY but it has increased by 11% QoQ
The current ratio has plunged by 72% YoY but it has grown by 5% from the previous quarter
The debt is 69% smaller than the equity
OPRX's equity is down by 5% since the previous quarter
OPRX's debt to equity is up by 3.3% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.